Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SMWB | VTS |
|---|---|---|
| Price | $8.13 | $17.03 |
| Change today | ▲ 1.25% | ▲ 0.41% |
| Market cap | $717.46M | $717.04M |
| Return, 3 months | +23.4% | +13.1% |
| Return, year to date | +8.5% | -5.0% |
| Return, 1 year | -8.5% | -19.3% |
| P/E (TTM) | -32.5 | -56.8 |
| P/B | 31.5 | 1.1 |
| P/E percentile vs own 5y | 22nd | 2nd |
| Dividend yield | – | 11.74% |
| Revenue growth (YoY, latest qtr) | +8.8% | +11.3% |
| Net profit growth (YoY) | +69.7% | +34.2% |
| Gross margin | 79.8% | 19.4% |
| Operating margin | -3.7% | 7.0% |
| Net margin | -7.4% | -4.0% |
| Return on equity | -94.0% | -1.7% |
| Analyst target vs. price | +26.7% | +26.2% |
| Analyst buy share | 67% | 75% |
| RSI (14) | 50 | 51 |
| 30-day volatility | 55.6% | 27.2% |
| Max drawdown, 1 year | -75.7% | -33.1% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
